Skip to main content
Bliss GVS Pharma Limited logo

Bliss GVS Pharma Limited — Investor Relations & Filings

Ticker · BLISSGVS ISIN · INE416D01022 LEI · 335800GXY3YCGGP7KJ45 BSE.NS Manufacturing
Open in API
Filings indexed 1,246 across all filing types
Latest filing 2019-09-30 Regulatory Filings
Country IN India
Listing BSE.NS BLISSGVS

About Bliss GVS Pharma Limited

https://blissgvs.com/

Bliss GVS Pharma Limited specializes in the development, manufacturing, and marketing of diverse pharmaceutical formulations. The company is a global leader in the production of suppositories and pessaries, maintaining an extensive portfolio within these specialized dosage forms. Its therapeutic focus includes anti-malarials, anti-fungals, anti-bacterials, anti-inflammatories, and gastrointestinal treatments. The organization operates state-of-the-art manufacturing facilities compliant with international quality standards, including WHO-GMP. With a strategic focus on emerging markets, the company distributes its range of prescription and over-the-counter products across Sub-Saharan Africa, Southeast Asia, and Latin America, leveraging a robust supply chain to provide accessible healthcare solutions.

Recent filings

Filing Released Lang Actions
In accordance with reference to the circulars issued by BSE vide Circular no. LIST/COMP/01/2019-20 and NSE vide Circular no. NSE/CML/2019/11 dated April 2, 2019 and in complying with the ....
Regulatory Filings
2019-09-30 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled 'Disclosure of Revised Voting Results of the 34th Annual General Meeting of Bliss GVS Pharma Limited held on September 20, 2019.' It contains detailed voting results for resolutions passed at the AGM, including approval of audited financial statements and declaration of dividends. The content focuses on the official results of shareholder votes at the AGM, which aligns with the category for Declaration of Voting Results & Voting Rights Announcements (DVA). The document is not the full AGM presentation or annual report but specifically the voting results disclosure. Therefore, the correct classification is DVA with high confidence.
2019-09-23 English
In continuation of our earlier letter dated 21.09.2019, we are submitting revised voting results of 34th Annual General Meeting of the Company held on Friday, September 20, 2019 in the ....
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Disclosure of Revised Voting Results of the 34th Annual General Meeting of Bliss GVS Pharma Limited held on September 20, 2019.' It contains detailed voting results for resolutions passed at the AGM, including adoption of financial statements, declaration of dividends, and reappointment of directors. The content focuses on the official results of shareholder votes at the AGM, which aligns with the category for Declaration of Voting Results & Voting Rights Announcements (DVA). The document is not the AGM presentation itself, nor is it an annual report or earnings release. It is also not a report publication announcement since it contains substantive voting data. Therefore, the correct classification is DVA with high confidence.
2019-09-23 English
Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Registrar and Share Transfer ....
Regulatory Filings
2019-09-23 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal communication addressed to stock exchanges (National Stock Exchange of India and BSE Limited) regarding the voting results of the 34th Annual General Meeting (AGM) of Bliss GVS Pharma Limited held on September 20, 2019. It includes detailed voting outcomes on resolutions such as adoption of financial statements and declaration of dividends. The presence of voting results, resolution numbers, and references to the AGM date clearly indicate this is a declaration of voting results document. There is no indication that this is the full AGM presentation or the annual report itself, but rather the official announcement of the voting outcomes from the AGM. Therefore, the appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA). The document length and detail support a high confidence in this classification.
2019-09-21 English
In accordance with the Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclosed herewith please find the voting results of 34th Annual General ....
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed report of voting results from the 34th Annual General Meeting (AGM) of Bliss GVS Pharma Limited held on September 20, 2019. It includes specific voting outcomes on resolutions such as adoption of financial statements and declaration of dividends, with vote counts and percentages for promoters and public shareholders. The presence of voting results, scrutinizer's report mention, and the context of an AGM clearly indicate this is a Declaration of Voting Results document. It is not the AGM presentation materials themselves, nor a full annual report or earnings release. Therefore, the appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA). The document length and detail support a high confidence score.
2019-09-21 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.